Zhihua Li

发表

FGF21 Analogs of Sustained Action Enabled by Orthogonal Biosynthesis Demonstrate Enhanced Antidiabetic Pharmacology in Rodents

Margaret S. Wu, D. Zaller, Thea C. Norman, 2012, Diabetes.

Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.

S. Biswas, Bei B. Zhang, Zhihua Li, 2004, The Biochemical journal.

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.

Margaret S. Wu, T. Doebber, D. Szalkowski, 2005, The Journal of clinical investigation.

Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance

D. Moller, N. Thornberry, S. Conarello, 2003, Proceedings of the National Academy of Sciences of the United States of America.

A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects.

D. Moller, V. Ding, S. Qureshi, 2004, Diabetes.

Peroxisome Proliferator-Activated Receptor (PPAR)-α Agonism Prevents the Onset of Type 2 Diabetes in Zucker Diabetic Fatty Rats: A Comparison with PPARγ Agonism

J. Berger, D. Moller, T. Doebber, 2006 .

Anti-Diabetic Efficacy and Impact on Amino Acid Metabolism of GRA1, a Novel Small-Molecule Glucagon Receptor Antagonist

Margaret S. Wu, S. Qureshi, J. Mu, 2012, PloS one.

Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis.

H. Wilkinson, D. Szalkowski, Howard Y. Chen, 2003, Molecular endocrinology.

Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists.

D. Gerhold, D. Holder, J. Berger, 2002, Endocrinology.

Regulation of insulin signal transduction pathway by a small-molecule insulin receptor activator.

D. Moller, D. E. Biazzo-Ashnault, V. Ding, 2002, The Biochemical journal.

Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic β-Cell Mass and Function in a Rodent Model of Type 2 Diabetes

Yue Feng, Yun-ping Zhou, D. Moller, 2006, Diabetes.

Ansuman Bagchi, Alex Elbrecht, Arthur Fridman, 2022 .

Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer ( PPAR g Agonist ) Action

Margaret S. Wu, J. Berger, D. Moller, 1998 .

Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes.

Yun-ping Zhou, N. Thornberry, J. Mu, 2009, European journal of pharmacology.

Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists.

Margaret S. Wu, J. Berger, D. Moller, 2002, Diabetes.

11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

R. Thieringer, J. Metzger, B. Pikounis, 2005, The Journal of experimental medicine.

Downstream Signaling Pathways in Mouse Adipose Tissues Following Acute In Vivo Administration of Fibroblast Growth Factor 21

Margaret S. Wu, R. Hendrickson, C. Paweletz, 2013, PloS one.

Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.

J. Berger, D. Moller, T. Doebber, 2006, Endocrinology.

Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes.

D. Moller, D. Szalkowski, Bei B. Zhang, 2004, Endocrinology.

Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.

R G Smith, D. Moller, J. Zierath, 1999, Science.

Inhibition of adipocyte differentiation by HIV protease inhibitors.

J. Berger, D. Moller, B. Zhang, 1999, The Journal of clinical endocrinology and metabolism.

Activation of Insulin Signal Transduction Pathway and Anti-diabetic Activity of Small Molecule Insulin Receptor Activators*

D. Moller, D. E. Biazzo-Ashnault, V. Ding, 2000, The Journal of Biological Chemistry.

Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice

S. Qureshi, G. Jiang, J. Mu, 2011, Diabetologia.

Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia

M. J. Charron, S. Conarello, G. Jiang, 2006, Diabetologia.

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.

Margaret S. Wu, T. Doebber, D. Szalkowski, 2005, The Journal of clinical investigation.

11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.

R. Thieringer, J. Metzger, B. Pikounis, 2005, The Journal of experimental medicine.

Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer ( PPAR g Agonist ) Action

J. Berger, D. Moller, J. Zierath, 1998 .